BD's Q4 Revenues Rise Sharply on CareFusion Acquisition | GenomeWeb

NEW YORK (GenomeWeb) – Becton Dickinson today reported a nearly 40 percent jump in its fiscal fourth quarter revenues, reflecting the company's acquisition of medical technology firm CareFusion earlier this year.

"We are very pleased with our strong finish to the year as a combined entity," BD CFO Christopher Reidy said during a conference call after the release of the company's earnings. "We significantly expanded our margins and captured approximately $50 million in synergy cost savings." 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.